A new chapter in flu prevention may be here. The FDA has approved Moderna’s mFlusiva, the first U.S. flu vaccine to use mRNA technology, bringing the same vaccine platform used for COVID-19 into seasonal influenza prevention. Joining us to break it all down is Dr. Steven Goldberg, Chief Medical Officer of HealthTrack.
About the Author
Sean Thrunk
Producer
Sean Thrunk is an award-winning multi-media journalist and graduate of Montclair State University.
He serves as ONNJ’s main editor and as a news producer for ONNJ Mornings with Ken Rosato!